<?xml version="1.0" encoding="utf-8"?>
<items><item><FP_UMLS_Trees><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Addison Disease  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0001403"&gt;&lt;i&gt;C0001403&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;A hormonal disorder that occurs when the adrenal glands fail to release adequate amounts of glucocorticoids (cortisol), mineralocorticoids (aldosterone, 11-deoxycorticosterone), and androgens (dehydroepiandrosterone) to meet physiologic needs, despite release of ACTH from the pituitary.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MEDLINEPLUS)&lt;/td&gt;
                &lt;td&gt;
                  &lt;span&gt;
                    &lt;p&gt;Your adrenal glands are just above your kidneys. The outside layer of these glands makes hormones that help your body respond to stress and regulate your blood pressure and water and salt balance.  Addison's disease occurs if the adrenal glands don't make enough of these hormones.&lt;/p&gt;
                    &lt;p&gt;A problem with your immune system usually causes Addison's disease. The immune system mistakenly attacks your own tissues, damaging your adrenal glands.&lt;/p&gt;
                    &lt;p&gt;Symptoms include&lt;/p&gt;
                    &lt;ul&gt;&lt;li&gt;Weight loss	&lt;/li&gt;
                      &lt;li&gt;Muscle weakness	&lt;/li&gt;
                      &lt;li&gt;Fatigue that gets worse over time	&lt;/li&gt;
                      &lt;li&gt;Low blood pressure	&lt;/li&gt;
                      &lt;li&gt;Patchy or dark skin &lt;/li&gt;
                    &lt;/ul&gt;&lt;p&gt;Lab tests can confirm that you have Addison's disease.  If you don't treat it, it can be fatal. You will need to take hormone pills for the rest of your life.  If you have Addison's disease, you should carry an emergency ID. It should say that you have the disease, list your medicines and say how much you need in an emergency.&lt;/p&gt;
                  &lt;/span&gt;
                &lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MSH)&lt;/td&gt;
                &lt;td&gt;An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CSP)&lt;/td&gt;
                &lt;td&gt;disease characterized by hypotension, weight loss, anorexia, weakness, and sometimes a bronze-like melanotic hyperpigmentation of the skin; due to tuberculosis or autoimmune induced disease (hypofunction) of the adrenal glands that results in deficiency of aldosterone and cortisol.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Disease or Syndrome (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0001403&amp;amp;tui=T047"&gt;&lt;i&gt;T047&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;MSH&lt;/td&gt;
                &lt;td&gt;D000224&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD10&lt;/td&gt;
                &lt;td&gt;E27.1&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;111562000, 367376006, 363732003, 373662000, 154707007, 267483004, 68588005&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;Disease, Addison, ADDISON DISEASE, ADDISON'S DISEASE, ADRENAL INSUFFICIENCY (ADDISON'S DISEASE), ADRENOCORTICAL INSUFFICIENCY, PRIMARY FAILURE, DISEASE ADDISON'S, Addison's disease, NOS, Primary adrenal deficiency, Primary adrenocortical insuff, Disease Addison's, Adrenal insufficiency (Addison disease), ADDISONS DIS, ADDISON DIS, Chronic Adrenal Insufficiency, Hypocortisolism, Addison's disease NOS, primary adrenal insufficiency, primary adrenal insufficiency (diagnosis), Addison's disease, NOS (disorder), Addison Disease, Addison disease, Addison Disease [Disease/Finding], Disease;Addisons, addison disease, addison's disease, Primary adrenal insufficiency, Addison's disease, Primary adrenocortical insufficiency, Primary hypoadrenalism, Addison's disease (disorder), Primary adrenocortical insufficiency (disorder), corticoadrenal; deficiency, primary, deficiency; adrenocortical, primary, deficiency; corticoadrenal, primary, disease (or disorder); bronzed skin (Addison) (bronze disease), hypoadrenocorticism; primary, insufficiency; adrenal, primary, insufficiency; suprarenal, primary, adrenal cortex; deficiency, primary, adrenal cortex; hypofunction, primary, adrenal; insufficiency, primary, primary; hypoadrenocorticism, Addison; disease or syndrome, suprarenal; insufficiency, primary, syndrome; Addison, Addison's disease [Ambiguous], Addison's Disease, Hypoadrenalism, Primary, Hypoadrenalisms, Primary, Insufficiencies, Primary Adrenocortical, Insufficiency, Primary Adrenocortical, Primary Adrenal Insufficiency, Primary Adrenocortical Insufficiencies, Primary Adrenocortical Insufficiency, Primary Hypoadrenalism, Adrenal Insufficiency, Primary, Adrenocortical Insufficiencies, Primary, Adrenocortical Insufficiency, Primary, Addisons Disease, Addisons disease&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;DOENCA DE ADDISON, Hipadrenalismo primário, Insuficiência suprarrenal primária, Doença de Addison&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Insufficienza surrenale primitiva, Malattia di Addison, Iposurrenalismo primitivo, Insufficienza corticosurrenale cronica, Insufficienza adrenocorticale primaria, Ipoadrenalismo primario, Morbo di Addison&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;primair hypoadrenalisme, ziekte van Addison, Addison; ziekte of syndroom, aandoening; bronzed skin (Addison) (bronsziekte), bijnier; insufficiëntie, primair, bijnierschors; deficiëntie, primair, bijnierschors; hypofunctie, primair, cortico-adrenaal; deficiëntie, primair, deficiëntie; bijnierschors, primair, deficiëntie; cortico-adrenaal, primair, hypoadrenocorticisme; primair, insufficiëntie; bijnier, primair, insufficiëntie; suprarenaal, primair, primair; hypoadrenocorticisme, suprarenaal; insufficiëntie, primair, syndroom; Addison, primaire bijnierinsufficiëntie, Addison, syndroom van, Addison, ziekte van, Ziekte van Addison, Primaire bijnierschorsinsufficiëntie&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;Hyposurrénalisme, MALADIE D'ADDISON, Insuffisance surrénalienne primaire, Insuffisance corticosurrénalienne primitive, Insuffisance surrénalienne primitive, Maladie d'Addison, Insuffisance surrénale lente, Insuffisance surrénale primitive&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;Krankheit Addisonsche, Addisonsche Krankheit, primaerer Hypoadrenalismus, MORBUS ADDISON, Primaere Nebennierenrindeninsuffizienz, primaere Nebenniereninsuffizienz, Addison-Krankheit, Bronzehautkrankheit, Nebenniereninsuffizienz, primär chronische&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;Hipoadrenalismo primario, Addison's disease, Addison's disease, NOS, ADDISON, ENFERMEDAD, enfermedad de Addison (concepto no activo), enfermedad de Addison (trastorno), enfermedad de Addison, insuficiencia adrenal crónica, insuficiencia adrenal primaria, insuficiencia adrenocortical primaria, insuficiencia corticosuprarrenal primaria (trastorno), insuficiencia corticosuprarrenal primaria, insuficiencia suprarrenal crónica, insuficiencia suprarrenal primaria, Insuficiencia suprarrenal primaria, Enfermedad de Addison&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;原発性副腎機能不全, 原発性副腎機能低下症, ｹﾞﾝﾊﾟﾂｾｲﾌｸｼﾞﾝｷﾉｳﾌｾﾞﾝ, ｱｼﾞｿﾝﾋﾞｮｳ, ｹﾞﾝﾊﾟﾂｾｲﾌｸｼﾞﾝｷﾉｳﾃｲｶｼｮｳ, Addison病, アジソン病, 副腎性黒皮症, 副腎機能不全症-原発性, 原発性副腎機能不全症, 原発性副腎皮質機能低下症, 慢性副腎皮質不全症, アディソン病, 副腎皮質機能低下症-原発性&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Swedish&lt;/td&gt;
                &lt;td&gt;Addisons sjukdom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;Addisonova nemoc, Primární hypoadrenalismus, Primární nadledvinová nedostatečnost, Addisonova choroba&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Finnish&lt;/td&gt;
                &lt;td&gt;Addisonin tauti&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Russian&lt;/td&gt;
                &lt;td&gt;ADDISONOVA BOLEZN', BRONZOVAIA BOLEZN', АДДИСОНОВА БОЛЕЗНЬ, БРОНЗОВАЯ БОЛЕЗНЬ&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Korean&lt;/td&gt;
                &lt;td&gt;원발성 부신피질 기능부전&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Croatian&lt;/td&gt;
                &lt;td&gt;ADDISONOVA BOLEST&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Polish&lt;/td&gt;
                &lt;td&gt;Choroba Addisona, Pierwotna przewlekła niedoczynność kory nadnerczy, Cisawica&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Addison-kór, Addison-betegség, Primaer mellékvese elégtelenség, Primaer hypadrenia&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Adrenal gland hypofunction  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0001623"&gt;&lt;i&gt;C0001623&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;An endocrine or hormonal disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex (Addison's disease or primary adrenal insufficiency) or to inadequate secretion of ACTH by the pituitary gland (secondary adrenal insufficiency).&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;A disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex as in Addison's disease or primary adrenal insufficiency.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MSH)&lt;/td&gt;
                &lt;td&gt;Conditions in which the production of adrenal CORTICOSTEROIDS falls below the requirement of the body. Adrenal insufficiency can be caused by defects in the ADRENAL GLANDS, the PITUITARY GLAND, or the HYPOTHALAMUS.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CSP)&lt;/td&gt;
                &lt;td&gt;abnormally diminished activity of the adrenal gland.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Disease or Syndrome (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0001623&amp;amp;tui=T047"&gt;&lt;i&gt;T047&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;MSH&lt;/td&gt;
                &lt;td&gt;D000309&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;237785004, 111563005, 386584007, 68588005, 190527008&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;ADRENAL INSUFFICIENCY, HYPOADRENALISM, ADRENAL HYPOFUNCTION, HYPOFUNCTION ADRENAL, Hypofunction, Adrenal Gland, hypoadrenalism, Adrenal insufficiency, NOS, INSUFFICIENCY ADRENAL, adrenal insufficiency, adrenal insufficiency (diagnosis), Adrenal gland hypofunction, Hypofunction adrenal, Adrenal insufficiency NOS, Insufficiency adrenal, Adrenal Cortical Insufficiency, Adrenal Insufficiency [Disease/Finding], Insufficiency;adrenal, adrenal failure, adrenal hypofunctions, adrenal insufficiencies, insufficiency adrenal, adrenal hypofunction, Adrenal failure, Adrenal hypofunction, Adrenal insufficiency, Adrenal hypofunction (disorder), Hypoadrenalism (disorder), Adrenal Gland Hypofunction, Hypoadrenalism, Adrenal Insufficiencies, Adrenal Insufficiency, Adrenal Gland Insufficiency&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;INSUFFISANCE SURRENALE, Hypofonction surrénalienne, Hypofonction surrénale, Insuffisance surrénalienne SAI, HYPOFONCTIONNEMENT SURRENAL, HYPOSURRENALISME, Insuffisance surrénale, Hypofonctionnement de la glande surrénale, Hypofonctionnement surrénalien, Insuffisance surrénalienne&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;NEBENNIERENUNTERFUNKTION, Nebenniereninsuffizenz NNB, Insuffizienz Nebenniere, Hypoadrenalismus, Unterfunktion Nebenniere, HYPOADRENALISMUS, NEBENNIERENINSUFFIZIENZ, Nebenniereninsuffizienz, Hypokortizismus, Nebennierenunterfunktion&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Insufficienza surrenale, Ipofunzione surrenale, Insufficienza surrenale NAS, Iposurrenalismo, Ipoadrenalismo, Ipofunzione della ghiandola surrenale&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;hypofunctie bijnier, bijnierinsufficiëntie NAO, insufficiëntie bijnier, hypoadrenalisme, bijnierhypofunctie, bijnierinsufficiëntie, Bijnierhypofunctie, Hypocorticisme, Hypofunctie, bijnier-, Bijniermerginsufficiëntie, Bijnierschorsinsufficiëntie, Bijnierinsufficiëntie, Insufficiëntie, bijnier-&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;Insuficiência supra-renal NE, Hipofunção supra-renal, Hipoadrenalismo, HIPOADRENALISMO, HIPOFUNCAO SUPRA-RENAL, INSUFICIENCIA SUPRA-RENAL, Insuficiência supra-renal, Hipofunção das Glândulas Supra-Renais, Insuficiência Adrenal, Insuficiência Supra-Renal&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;Insuficiencia suprarrenal NEOM, Insuficiencia adrenal, Hipofunción suprarrenal, Hipoadrenalismo, Adrenal hypofunction, HIPOADRENALISMO, INSUFICIENCIA SUPRARRENAL, SUPRARRENAL HIPOFUNCION, hipoadrenalismo (trastorno), hipoadrenalismo, hipofunción adrenal, hipofunción suprarrenal (trastorno), hipofunción suprarrenal, Insuficiencia suprarrenal, Hipofunción de las Glándulas Suprarrenales, Insuficiencia Suprarrenal, Hipofuncion de las Glandulas Suprarrenales&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;副腎機能不全ＮＯＳ, 副腎機能不全, ﾌｸｼﾞﾝｷﾉｳﾃｲｶ, ﾌｸｼﾞﾝｷﾉｳﾌｾﾞﾝNOS, ﾌｸｼﾞﾝｷﾉｳﾃｲｶｼｮｳ, ﾌｸｼﾞﾝｷﾉｳﾌｾﾞﾝ, 副腎皮質機能低下症, 副腎機能低下, 副腎機能低下症, 副腎皮質機能低下&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Swedish&lt;/td&gt;
                &lt;td&gt;Binjurehypofunktion&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;nadledviny - hypofunkce, Nedostatečnost nadledvin NOS, Nedostatečnost nadledvin, Adrenální hypofunkce, Adrenální nedostatečnost, Hypoadrenalismus, nadledviny - insuficience, insuficience nadledvin&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Finnish&lt;/td&gt;
                &lt;td&gt;Lisämunuaisen vajaatoiminta&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Russian&lt;/td&gt;
                &lt;td&gt;NADPOCHECHNIKOV NEDOSTATOCHNOST', NADPOCHECHNIKOV GIPOFUNKTSIIA, НАДПОЧЕЧНИКОВ ГИПОФУНКЦИЯ, НАДПОЧЕЧНИКОВ НЕДОСТАТОЧНОСТЬ&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Croatian&lt;/td&gt;
                &lt;td&gt;Not Translated[Adrenal Insufficiency]&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Polish&lt;/td&gt;
                &lt;td&gt;Niewydolność kory nadnerczy, Niedoczynność kory nadnerczy&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Mellékvese-elégtelenség, Adrenalis hypofunctio, Hypadrenia, Mellékvese elégtelenség, Mellékvese hypofunctio, Mellékvese-elégtelenség k.m.n.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Adrenal cortical hypofunction  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0405580"&gt;&lt;i&gt;C0405580&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Disease or Syndrome (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0405580&amp;amp;tui=T047"&gt;&lt;i&gt;T047&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD9&lt;/td&gt;
                &lt;td&gt;255.4&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;267398003, 386584007, 154707007, 267483004, 68588005, 190527008&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;ADRENAL CORTEX INSUFFIENCY, ADRENAL CORTEX HYPOFUNCTION, ADRENAL CORTICAL INSUFFICIENCY, INSUFFICIENCY ADRENAL CORTEX, Adrenal cortical hypofunction, NOS, Adrenocortical hypofunction, NOS, Corticoadrenal insufficiency, NOS, Hypoadrenocorticism, NOS, Corticoadrenal insuffic. NOS, Corticoadrenal insufficiency NOS, Adrenocortical insufficiency syndrome, Adrenal insufficiency NOS, Adrenal cortex hypofunction, Adrenal cortex insuffiency, Adrenal cortical insufficiency, Insufficiency adrenal cortex, Adrenal cortex insufficiency, corticoadrenal insufficiency (diagnosis), corticoadrenal insufficiency, adrenal cortical hypofunction, adrenal cortical insufficiency, Adrenal cortical hypofunction, Adrenal insufficiency, ADRENAL INSUFFICIENCY CORTICAL, Corticoadrenal insufficiency NOS (disorder), adrenal insufficiency, adrenal insufficiencies, adrenal cortex insufficiency, adrenocortical hypofunction, Adrenal Insufficiency, Adrenal cortical hypofunctions, Corticoadrenal insufficiency, Hypoadrenocorticism, Adrenal cortical hypofunction (disorder), Adrenocortical hypofunction, corticoadrenal; deficiency, corticoadrenal; hypofunction, deficiency; corticoadrenal, hypoadrenocorticism, hypofunction; adrenocortical, insufficiency; adrenal, adrenal cortex; deficiency, adrenal; insufficiency&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Ipofunzioni corticosurrenali, Ipocorticosurrenalismo, Insufficienza corticosurrenale, Insufficienza della corteccia surrenale, Ipofunzione corticosurrenale&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;副腎皮質機能低下, ﾌｸｼﾞﾝﾋｼﾂｷﾉｳﾃｲｶ, 副腎皮質機能不全, ﾌｸｼﾞﾝﾋｼﾂｷﾉｳﾌｾﾞﾝ, 副腎皮質機能低下症, ﾌｸｼﾞﾝﾋｼﾂｷﾉｳﾃｲｶｼｮｳ&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;Corticoadrenal insufficiency, Corticoadrenal insufficiency NOS, Hipoadrenocorticismo, Hipofunción corticosuprarrenal, Insuficiencia de la corteza suprarrenal, Hipofunción cortical suprarrenal, Insuficiencia córticosuprarrenal, Insuficiencia corticoadrenal, CORTEZA SUPRARRENAL, HIPOFUNCION, CORTICOSUPRARRENAL, INSUFICIENCIA, hipoadrenocorticismo, hipofunción adrenocortical, hipofunción de corteza adrenal (trastorno), hipofunción de corteza adrenal, insuficiencia corticoadrenal, SAI (trastorno), insuficiencia corticoadrenal, SAI, insuficiencia corticoadrenal, insuficiencia corticosuprarrenal, insuficiencia suprarrenal (trastorno), insuficiencia suprarrenal, Hipofunción de la corteza suprarrenal&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;Insuffisance corticosurrénale, Insuffisance cortico-surrénalienne, Hypofonction cortico-surrénale, Insuffisance corticale surrénalienne, Hypoadrénocorticisme, Insuffisance corticosurrénalienne, Hypofonction de la corticosurrénale, Insuffisance cortico-surrénale, HYPOFONCTIONN CORTICO-SURRENAL, INSUFFISANCE CORTICO-SURRENALE, Hypofonctions adréno-corticales&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;bijnierschorshypofunctie, hypoadrenocorticisme, insufficiëntie bijnierschors, bijnierschorsinsufficiëntie, bijnier; insufficiëntie, bijnierschors; deficiëntie, bijnierschors; hypofunctie, cortico-adrenaal; deficiëntie, deficiëntie; cortico-adrenaal, hypofunctie; bijnierschors, insufficiëntie; bijnier, bijnierschorshypofuncties&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;Insuficiência córtico-supra-renal, Insuficiência cortical suprarrenal, Hipoadrenocorticismo, Hipofunção córtico-supra-renal, Insuficiência adrenocortical, HIPOFUNCAO DO CORTEX SUPRA-RENAL, INSUFICIENCIA CORTICO-SUPRA-RENAL, Hipofuncionamento cortical suprarenal&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;Nebennierenrindenunterfunktion, Hypoadrenokortizismus, Insuffizienz der Nebennierenrinde, kortikoadrenale Insuffizienz, Nebennierenrindeninsuffizienz, NNR INSUFFIZIENZ, NNR UNTERFUNKTION, Unterfunktionen der Nebennierenrinde&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;Hypofunkce nadledvinové kůry, Adrenokortikální nedostatečnost, Hypofunkce kůry nadledvin, Adrenokortikální hypofunkce, Nedostatečnost kůry nadledvin, Hypoadrenokorticismus, Insuficience kůry nadledvin, Insuficience adrenálního kortexu, Kortikoadrenální nedostatečnost&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;adrenocorticalis elégtelenség, Mellékvesekéreg insufficientia, Mellékvesekéreg insufficiencia, Corticoadrenalis elégtelenség, Adrenocorticalis hypofunkciók, Mellékvese kéreg hypofunctio, Mellékvesekéreg hypofunctio, Mellékvesekéreg elégtelensége, adrenocorticalis hypofunctio&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Addisonian crisis  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0151467"&gt;&lt;i&gt;C0151467&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Disease or Syndrome (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0151467&amp;amp;tui=T047"&gt;&lt;i&gt;T047&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD10&lt;/td&gt;
                &lt;td&gt;E27.2&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;190522002, 190526004, 237757001, 24867002, 154707007, 267483004&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;ADDISONIAN CRISIS, ADRENAL APOPLEXY, ADRENAL CRISIS, ADRENAL STORM, ADRENOCORTICAL INSUFFICIENCY, ACUTE, CRISIS ADDISONIAN, CRISIS ADRENAL, Addisonian crisis, Adrenal Apoplexy, Adrenocortical insufficiency syndrome, acute, Adrenal crisis syndrome, adrenal crisis (diagnosis), adrenal crisis, Adrenal storm, Acute adrenal insufficiency (&amp;amp; [Addisonian crisis] or [adrenal crisis]) (disorder), Addisonian crisis (disorder), Addisonian crisis (diagnosis), Adrenocortical insufficiency acute, Crisis addisonian, Crisis adrenal, acute adrenal insufficiency, addisonian crisis, adrenal storm, severe adrenal insufficiency, Adrenal crisis, Severe adrenal insufficiency, Acute adrenal insufficiency, Adrenocortical crisis, Severe adrenal insufficiency (disorder), collapse; adrenal, crisis; Addison, crisis; adrenal, adrenal; collapse, adrenal; crisis, adrenal; shock, Addison; crisis, shock; adrenal, Acute adrenal insufficiency (&amp;amp; [Addisonian crisis] or [adrenal crisis])&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Insufficienza corticosurrenale acuta, Crisi surrenale, Crisi Addisoniana, Crisi addisoniana, Tempesta surrenale&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;adrenale crisis, Addison-crisis, crisis bijnier, adrenale storm, Addison; crisis, adrenaal; crisis, bijnier; collaps, bijnier; shock, collaps; bijnier, crisis; Addison, crisis; adrenaal, shock; bijnier, acute bijnierschorsinsufficiëntie&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;Crise d'Addison, Crise surrénale, Crise d'insuffisance surrénale, Crise surrénalienne, CATACLYSME SURRENAL, CRISE SURRENALE, Insuffisance surrénalienne aiguë&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;Nebennierenkrise, Krise Nebenniere, Krise Addison, Addison-Krise, ADDISONKRISE, akute Nebennierenrindenueberfunktion, NEBENNIERENKRISE, Nebennierenrindeninsuffizienz akut&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;Crise de Addison, Crise addisoniana, Crise supra-renal, Perturbação supra-renal, CRISE SUPRA-RENAL, Insuficiência adrenocortical aguda&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;Crisis adrenal, Crisis addisoniana, Addisonian crisis, Acute adrenal insufficiency (&amp;amp; [Addisonian crisis] or [adrenal crisis]), Acute adrenal insufficiency, Adrenal crisis, Tormenta adrenal, CRISIS SUPRARRENAL, SUPRARRENAL, CRISIS, crisis addisoniana, crisis suprarrenal, insuficiencia adrenal severa, insuficiencia suprarrenal aguda (trastorno), insuficiencia suprarrenal aguda, insuficiencia suprarrenal severa, Insuficiencia córticosuprarrenal aguda&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;アジソン病クリーゼ, 急性副腎皮質機能不全, 副腎クリーゼ, ｷｭｳｾｲﾌｸｼﾞﾝﾋｼﾂｷﾉｳﾌｾﾞﾝ, ｱｼﾞｿﾝﾋﾞｮｳｸﾘｰｾﾞ, ﾌｸｼﾞﾝｸﾘｰｾﾞ, ﾌｸｼﾞﾝｽﾄｰﾑ, 副腎ストーム&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;Addisonská krize, Adrenální krize, Adrenal storm (Akutní vyplavení hormonů kůry nadledvin), Akutní nedostatečnost kůry nadledvin&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Korean&lt;/td&gt;
                &lt;td&gt;아디슨 발증&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Addison-crisis, Adrenalis crisis, Mellékvese izgalom, Acut mellékvesekéreg elégtelenség, Addisonos crisis&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value></FP_UMLS_Trees><FP_Condition_name_check><value>Addison Disease  (</value><value>)
</value><value>Adrenal gland hypofunction  (</value><value>)
</value><value>Adrenal cortical hypofunction  (</value><value>)
</value><value>Addisonian crisis  (</value><value>)
</value></FP_Condition_name_check><FP_Condition_name><value>Addison's Disease</value></FP_Condition_name><FP_SubChap_name><value>Endocrinology: Adrenal Disease</value></FP_SubChap_name><FP_Condition_Tree><value>&lt;ol&gt;&lt;li&gt;See Also&lt;ol&gt;&lt;li&gt;&lt;a href="../../Endo/Adrenal/AtmnPlyglndlrSyndrmTypI.htm" class="LinkPage"&gt;Autoimmune Polyglandular Syndrome&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Pathophysiology&lt;ol&gt;&lt;li&gt;Hypothalamic-Pituitary-Adrenal Axis (HPA) Dysfunction&lt;ol&gt;&lt;li&gt;Lab features: Cortisol low, ACTH Low&lt;/li&gt;&lt;li&gt;Causes&lt;ol&gt;&lt;li&gt;Severe illness&lt;/li&gt;&lt;li&gt;Exogenous &lt;a href="../../Endo/Pharm/SystmcCrtcstrd.htm" class="LinkPage"&gt;Corticosteroid&lt;/a&gt; (suppression lasts months)&lt;ol&gt;&lt;li&gt;Prednisone &amp;gt;7.5 mg/day for &amp;gt;3 weeks&lt;/li&gt;&lt;li&gt;&lt;a href="../../Endo/Pharm/SystmcCrtcstrd.htm" class="LinkPage"&gt;Dexamethasone&lt;/a&gt; &amp;gt;0.75 mg/day for &amp;gt;3 weeks&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Pituitary Infarction&lt;/li&gt;&lt;li&gt;&lt;a href="../../Neuro/ID/CnsInfctn.htm" class="LinkPage"&gt;CNS Infection&lt;/a&gt; or tumor invasion&lt;/li&gt;&lt;li&gt;&lt;a href="../../ER/Neuro/HdInjry.htm" class="LinkPage"&gt;Head Injury&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../HIV/Exam/HmnImndfcncyVrs.htm" class="LinkPage"&gt;HIV Infection&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Adrenal Insufficiency&lt;ol&gt;&lt;li&gt;Lab features: Cortisol low, ACTH high&lt;/li&gt;&lt;li&gt;Causes&lt;ol&gt;&lt;li&gt;Addison's Disease&lt;ol&gt;&lt;li&gt;Primary adrenal failure of &lt;a href="../../Endo/Anatomy/AdrnlAntmy.htm" class="LinkPage"&gt;Adrenal Gland&lt;/a&gt;s&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Idiopathic adrenal hypoplasia or destruction&lt;ol&gt;&lt;li&gt;Granulomatous disease (e.g. &lt;a href="../../Lung/Tb/Tbrcls.htm" class="LinkPage"&gt;Tuberculosis&lt;/a&gt;, Fungus)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Rheum/Diffuse/Amylds.htm" class="LinkPage"&gt;Amyloidosis&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../GI/HemeOnc/Hmchrmts.htm" class="LinkPage"&gt;Hemochromatosis&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Tumor&lt;/li&gt;&lt;li&gt;Autoimmune process&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Drug mediated cortisol inhibition&lt;ol&gt;&lt;li&gt;&lt;a href="../../Surgery/Pharm/Etmdt.htm" class="LinkPage"&gt;Etomidate&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../ID/Pharm/Ktcnzl.htm" class="LinkPage"&gt;Ketoconazole&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Symptoms&lt;ol&gt;&lt;li&gt;Weakness&lt;/li&gt;&lt;li&gt;&lt;a href="../../Rheum/Sx/Ftg.htm" class="LinkPage"&gt;Fatigue&lt;/a&gt; or Lethargy&lt;/li&gt;&lt;li&gt;&lt;a href="../../GI/Sx/Vmtng.htm" class="LinkPage"&gt;Nausea&lt;/a&gt; or &lt;a href="../../GI/Sx/Vmtng.htm" class="LinkPage"&gt;Vomiting&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../GI/Diarrhea/ActDrh.htm" class="LinkPage"&gt;Diarrhea&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Surgery/GI/ActAbdmnlPn.htm" class="LinkPage"&gt;Abdominal Pain&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Weight loss&lt;/li&gt;&lt;li&gt;Salt craving&lt;/li&gt;&lt;li&gt;&lt;a href="../../Neuro/LOC/AltrdLvlOfCnscsns.htm" class="LinkPage"&gt;Altered Level of Consciousness&lt;/a&gt; (e.g. &lt;a href="../../Neuro/Cognitive/Dlrm.htm" class="LinkPage"&gt;Delirium&lt;/a&gt;)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Signs&lt;ol&gt;&lt;li&gt;&lt;a href="../../ID/Exam/Fvr.htm" class="LinkPage"&gt;Fever&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Derm/Pigment/Hyprpgmntn.htm" class="LinkPage"&gt;Hyperpigmentation&lt;/a&gt;&lt;ol&gt;&lt;li&gt;Skin with mottled areas of increased pigmentation&lt;/li&gt;&lt;li&gt;Pigment at &lt;a href="../../Dental/Exam/LblMcs.htm" class="LinkPage"&gt;Buccal mucosa&lt;/a&gt; (Caucasian)&lt;/li&gt;&lt;li&gt;Increased pigment in lips, vagina, rectum&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Reduced &lt;a href="../../Derm/Anatomy/Hr.htm" class="LinkPage"&gt;Hair Growth&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Exam/OrthstcHyptnsn.htm" class="LinkPage"&gt;Postural Hypotension&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Signs of dehydration&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Labs&lt;ol&gt;&lt;li&gt;&lt;a href="../../HemeOnc/Lab/CmpltBldCnt.htm" class="LinkPage"&gt;Complete Blood Count&lt;/a&gt;&lt;ol&gt;&lt;li&gt;Normochromic &lt;a href="../../HemeOnc/Anemia/NrmcytcAnm.htm" class="LinkPage"&gt;Normocytic Anemia&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../HemeOnc/Lab/EsnphlCnt.htm" class="LinkPage"&gt;Eosinophilia&lt;/a&gt; (helps differentiate from other causes)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Chemistry Panel&lt;ol&gt;&lt;li&gt;&lt;a href="../../Renal/Sodium/Hypntrm.htm" class="LinkPage"&gt;Hyponatremia&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Renal/Chloride/Hypchlrm.htm" class="LinkPage"&gt;Hypochloremia&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Renal/Potassium/Hyprklm.htm" class="LinkPage"&gt;Hyperkalemia&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Endo/Hypoglycemia/Hypglycm.htm" class="LinkPage"&gt;Hypoglycemia&lt;/a&gt; (helps differentiate from other causes)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Urine 17-ketosteroids low&lt;/li&gt;&lt;li&gt;Urine 17-Hydroxysteroids low&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Diagnosis&lt;ol&gt;&lt;li&gt;Corticotropin Stimulation Test&lt;ol&gt;&lt;li&gt;Failed adrenal response&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Management&lt;ol&gt;&lt;li&gt;See &lt;a href="../../Endo/Surgery/PrprtvCrtcstrd.htm" class="LinkPage"&gt;Stress Dose Steroid&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Acute&lt;ol&gt;&lt;li&gt;IV Cortisol&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Chronic Replacement&lt;ol&gt;&lt;li&gt;&lt;a href="../../Endo/Pharm/SystmcCrtcstrd.htm" class="LinkPage"&gt;Hydrocortisone&lt;/a&gt; (glucocorticoid) AND&lt;/li&gt;&lt;li&gt;Mineralocorticoid (9-alpha-fluorocortisol)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Resources&lt;ol&gt;&lt;li&gt;Addison and Cushing International Federation (ACIF)&lt;ol&gt;&lt;li&gt;&lt;a href="http://www.nvacp.nl/page.php?main=5" class="LinkWebExt"&gt;http://www.nvacp.nl/page.php?main=5&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;References&lt;ol&gt;&lt;li&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;amp;db=PubMed&amp;amp;amp;term=Cooper%20%20%5BAU%5D%20AND%202003%20%5BDP%5D%20AND%20%20N%20Engl%20J%20Med%20%20%5BTA%5D" class="LinkRef"&gt;Cooper (2003) N Engl J Med 348:727-34&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
          &lt;/ol&gt;</value></FP_Condition_Tree><FP_Condition_ID><value>C0001403</value><value>C0001623</value><value>C0405580</value><value>C0151467</value></FP_Condition_ID><FP_SubChap_LinkTo><value>http://www.fpnotebook.com/Endo/Adrenal/AdsnsDs.htm</value></FP_SubChap_LinkTo><FP_Condition_aka><value>Aka: Addison's Disease, Addisonian Crisis, Adrenal Cortical Insufficiency, Adrenal Insufficiency, Adrenal Hypofunction, Illness Induced Adrenal Insufficiency</value></FP_Condition_aka><FP_SubChap_url>http://www.fpnotebook.com/Endo/Adrenal/index.htm</FP_SubChap_url></item><item><FP_UMLS_Trees><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Cushing Syndrome  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0010481"&gt;&lt;i&gt;C0010481&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;A syndrome caused by high levels of cortisol in the blood either due to excessive production and secretion of corticosteroids secondary to pituitary or adrenocortical neoplasms, or intake of glucocorticoid drugs. Signs and symptoms include a round face, upper body obesity, fragile and thin skin, purple stretch marks in the skin, fatigue, muscle weakness, hypertension, diabetes mellitus, hypertrichosis and amenorrhea in women, impotence in men, and osteoporosis.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CHV)&lt;/td&gt;
                &lt;td&gt;a rare hormonal disease that occurs when the body produces too much of the hormone cortisol&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CHV)&lt;/td&gt;
                &lt;td&gt;a rare hormonal disease that occurs when the body produces too much of the hormone cortisol&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MEDLINEPLUS)&lt;/td&gt;
                &lt;td&gt;
                  &lt;span&gt;
                    &lt;p&gt;Cushings syndrome is caused by long-term exposure to too much cortisol, a hormone that your adrenal gland makes. Sometimes, taking synthetic hormone medicine to treat an inflammatory disease leads to Cushing's. Some kinds of tumors secrete a hormone that can cause your body to make too much cortisol. &lt;/p&gt;
                    &lt;p&gt;Cushing's syndrome is rare. Some symptoms are &lt;/p&gt;
                    &lt;ul&gt;&lt;li&gt;Upper body obesity &lt;/li&gt;
                      &lt;li&gt;Thin arms and legs&lt;/li&gt;
                      &lt;li&gt;Severe fatigue and muscle weakness&lt;/li&gt;
                      &lt;li&gt;High blood pressure&lt;/li&gt;
                      &lt;li&gt;High blood sugar&lt;/li&gt;
                      &lt;li&gt;Easy bruising&lt;/li&gt;
                    &lt;/ul&gt;&lt;p&gt;Your treatment will depend on why you have too much cortisol. If it is because you have been taking synthetic hormones, a lower dose may control your symptoms. If a tumor caused it, surgery and other therapies may be needed.  Most of the time, Cushing's syndrome can be cured. &lt;/p&gt;
                    &lt;p style="font-weight:bold;font-style:italic;"&gt;NIH: National Institute of Neurological Disorders and Stroke&lt;/p&gt;
                  &lt;/span&gt;
                &lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;A condition in which there is too much cortisol (a hormone made by the outer layer of the adrenal gland) in the body. Cushing syndrome may be caused by taking too many steroid drugs or by certain types of tumors. Tumors that make adrenocorticotropic hormone (ACTH) cause the adrenal gland to make too much cortisol. Symptoms of Cushing syndrome include a round face, thin arms and legs, severe fatigue and muscle weakness, high blood pressure, high blood sugar, purple or pink stretch marks on the skin, and weight gain, especially in the abdomen.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;A condition in which there is too much cortisol (a hormone made by the outer layer of the adrenal gland) in the body. In Cushing disease, this happens when an adenoma (benign tumor) in the pituitary gland makes too much adrenocorticotropic hormone (ACTH). This causes the adrenal gland to make too much cortisol. Symptoms include a round face, thin arms and legs, severe fatigue and muscle weakness, high blood pressure and high blood sugar, purple or pink stretch marks on the skin, and weight gain, especially in the abdomen.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MSH)&lt;/td&gt;
                &lt;td&gt;A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CSP)&lt;/td&gt;
                &lt;td&gt;condition, more commonly seen in females, due to hyperadrenocorticism resulting from neoplasms of the adrenal cortex or the anterior lobe of the pituitary, or to prolonged excessive intake of glucocorticoids for therapeutic purposes; symptoms and signs may include rapidly developing adiposity of the face, neck, and trunk, kyphosis caused by osteoporosis of the spine, hypertension, diabetes mellitus, amenorrhea, hypertrichosis in females, impotence in males, dusky complexion with purple markings, polycythemia, pain in the abdomen and back, and muscular wasting and weakness.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Disease or Syndrome (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0010481&amp;amp;tui=T047"&gt;&lt;i&gt;T047&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;MSH&lt;/td&gt;
                &lt;td&gt;D003480&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD9&lt;/td&gt;
                &lt;td&gt;255.0&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD10&lt;/td&gt;
                &lt;td&gt;E24, E24.9&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;154705004, 190505004, 47270006&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;Cushing Syndrome, Cushing's Syndrome, Syndrome, Cushing's, CUSHINGS SYNDROME, CUSHING SYNDROME, CUSHING'S SYNDROME, SYNDROME CUSHING'S, Cushing's syndrome NOS, Cushing's syndrome, unspecified, Cushing syndrome, Cushing's basophilism, pituitary basophilism, Syndrome, Cushing, Cushing's syndrome (diagnosis), Cushing's syndrome (disorder), Cushings syndrome, Syndrome Cushing's, CUSHING, Cushing's syndrome NOS (disorder), Cushing Syndrome [Disease/Finding], cushing's syndrome, cushing syndrome, Cushing disease, Cushing's syndrome, Cushing's syndrome III, Itsenko disease, Itsenko-Cushing syndrome, Suprarenogenic syndrome, Hypercortisolism, Cushings Syndrome, cushings syndrome&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;SINDROME DE CUSHING, Síndrome de Cushing&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;SINDROME DE CUSHING, Cushing's syndrome, síndrome de Cushing, SAI (trastorno), síndrome de Cushing, SAI, síndrome de Cushing, síndrome de Itsenko - Cushing, Sindrome de Cushing, Síndrome de Cushing&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;syndroom van Cushing, Syndroom van Cushing, niet gespecificeerd, Cushing-syndroom, Syndroom van Cushing, Syndroom, Cushing-&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;Syndrom, Cushing, CUSHING SYNDROM, Cushing-Syndrom, nicht naeher bezeichnet, Cushing Syndrom, Cushing-Syndrom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Swedish&lt;/td&gt;
                &lt;td&gt;Cushings syndrom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;ｸｯｼﾝｸﾞｼｮｳｺｳｸﾞﾝ, Cushing症候群, クッシング症候群, 下垂体好塩基細胞腺腫, 脳下垂体好塩基細胞腺腫&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;Cushingův syndrom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Finnish&lt;/td&gt;
                &lt;td&gt;Cushingin oireyhtymä&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Russian&lt;/td&gt;
                &lt;td&gt;ITSENKO-KUSHINGA BOLEZN', ITSENKO-KUSHINGA SINDROM, KUSHINGA SINDROM, ИЦЕНКО-КУШИНГА БОЛЕЗНЬ, ИЦЕНКО-КУШИНГА СИНДРОМ, КУШИНГА СИНДРОМ&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;SYNDROME DE CUSHING, Syndrome de Cushing, Hypercortisolisme&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Ipercortisolismo, Sindrome di Cushing&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Korean&lt;/td&gt;
                &lt;td&gt;쿠싱 증후군, 상세불명의 쿠싱 증후군&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Croatian&lt;/td&gt;
                &lt;td&gt;CUSHINGOV SINDROM&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Polish&lt;/td&gt;
                &lt;td&gt;Zespół Cushinga&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Cushing syndroma, Cushing-syndroma, Cushing-tünetegyüttes&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value></FP_UMLS_Trees><FP_Condition_name_check><value>Cushing Syndrome  (</value><value>)
</value></FP_Condition_name_check><FP_Condition_name><value>Cushing's Disease</value></FP_Condition_name><FP_SubChap_name><value>Endocrinology: Adrenal Disease</value></FP_SubChap_name><FP_Condition_Tree><value>&lt;ol&gt;&lt;li&gt;Etiologies&lt;ol&gt;&lt;li&gt;Iatrogenic&lt;ol&gt;&lt;li&gt;Steroid therapy (most common cause)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Central Cause&lt;ol&gt;&lt;li&gt;Pituitary adenoma&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Adrenal Cause&lt;ol&gt;&lt;li&gt;Adrenal Adenoma&lt;/li&gt;&lt;li&gt;Adrenal Hyperplasia&lt;/li&gt;&lt;li&gt;Adrenal Malignancy (15%)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Ectopic Source&lt;ol&gt;&lt;li&gt;Malignancy (Small Cell Carcinoma of the lung: 15%)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Symptoms&lt;ol&gt;&lt;li&gt;Mood changes (depression and euphoria)&lt;/li&gt;&lt;li&gt;Easy bruising&lt;/li&gt;&lt;li&gt;Weakness&lt;/li&gt;&lt;li&gt;Weight gain&lt;/li&gt;&lt;li&gt;&lt;a href="../../Gyn/Sx/Amnrh.htm" class="LinkPage"&gt;Amenorrhea&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Back pain&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Signs&lt;ol&gt;&lt;li&gt;Truncal &lt;a href="../../Endo/Obesity/Obsty.htm" class="LinkPage"&gt;Obesity&lt;/a&gt; (90%)&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt; (85%)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Endo/DM/InslnRstncSyndrm.htm" class="LinkPage"&gt;Glucose Intolerance&lt;/a&gt; (80%)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Derm/Hair/Hrstsm.htm" class="LinkPage"&gt;Hirsutism&lt;/a&gt; (70%)&lt;/li&gt;&lt;li&gt;Wide, purple abdominal and thigh striae (65%)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Rheum/Bone/Ostprs.htm" class="LinkPage"&gt;Osteoporosis&lt;/a&gt; (55%)&lt;/li&gt;&lt;li&gt;Moon facies&lt;/li&gt;&lt;li&gt;Buffalo hump (Thoracic kyphosis)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Neuro/Motor/Mypthy.htm" class="LinkPage"&gt;Myopathy&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Plethoric face&lt;/li&gt;&lt;li&gt;Supraclavicular fat pad development&lt;/li&gt;&lt;li&gt;&lt;a href="../../Derm/Hair/Hyprtrchs.htm" class="LinkPage"&gt;Hypertrichosis&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Peripheral &lt;a href="../../Renal/Edema/Edm.htm" class="LinkPage"&gt;Edema&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Labs&lt;ol&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/ScrngTst.htm" class="LinkPage"&gt;Screening Test&lt;/a&gt;&lt;ol&gt;&lt;li&gt;&lt;a href="../../Endo/Lab/FrUrnCrtsl.htm" class="LinkPage"&gt;24-hour Urinary free cortisol level&lt;/a&gt; (preferred)&lt;ol&gt;&lt;li&gt;&lt;a href="../../Endo/Lab/FrUrnCrtsl.htm" class="LinkPage"&gt;Urine 17-Ketosteroid excretion&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Endo/Lab/FrUrnCrtsl.htm" class="LinkPage"&gt;Urine 17-Hydroxysteroid excretion&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Endo/Lab/SrmCrtsl.htm" class="LinkPage"&gt;Serum Cortisol&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Low dose &lt;a href="../../Endo/Lab/DxmthsnSprsnTst.htm" class="LinkPage"&gt;Dexamethasone Suppression Test&lt;/a&gt;&lt;ol&gt;&lt;li&gt;&lt;a href="../../Endo/Pharm/SystmcCrtcstrd.htm" class="LinkPage"&gt;Dexamethasone&lt;/a&gt; 1 mg at 11pm&lt;/li&gt;&lt;li&gt;Plasma Cortisol in following 8 AM&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Night-time &lt;a href="../../ENT/Anatomy/SlvryGlndAntmy.htm" class="LinkPage"&gt;Saliva&lt;/a&gt;ry cortisol testing&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Distinguish between pituitary, adrenal or ectopic cause&lt;ol&gt;&lt;li&gt;Plasma ACTH&lt;/li&gt;&lt;li&gt;High dose &lt;a href="../../Endo/Lab/DxmthsnSprsnTst.htm" class="LinkPage"&gt;Dexamethasone Suppression Test&lt;/a&gt; (8 mg)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Radiology&lt;ol&gt;&lt;li&gt;CT or MRI Cone down Sella Turcica&lt;ol&gt;&lt;li&gt;Pituitary adenoma&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;CT &lt;a href="../../GI/Anatomy/AbdmnlAntmy.htm" class="LinkPage"&gt;Abdomen&lt;/a&gt;&lt;ol&gt;&lt;li&gt;Adrenal tumor&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Management&lt;ol&gt;&lt;li&gt;Exogenous Cushing's&lt;ol&gt;&lt;li&gt;Stop steroids or decrease dose&lt;/li&gt;&lt;li&gt;Change steroid dosing to qod with drug holiday&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Endogenous Cushing's&lt;ol&gt;&lt;li&gt;Surgically excise adenoma (in pituitary or adrenal)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Resources&lt;ol&gt;&lt;li&gt;Addison and Cushing International Federation (ACIF)&lt;ol&gt;&lt;li&gt;&lt;a href="http://www.nvacp.nl/page.php?main=5" class="LinkWebExt"&gt;http://www.nvacp.nl/page.php?main=5&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;References&lt;ol&gt;&lt;li&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;amp;amp;db=PubMed&amp;amp;amp;term=Orth%20%20%5BAU%5D%20AND%201995%20%5BDP%5D%20AND%20%20N%20Engl%20J%20Med%20%20%5BTA%5D" class="LinkRef"&gt;Orth (1995) N Engl J Med 332:791-803&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
          &lt;/ol&gt;</value></FP_Condition_Tree><FP_Condition_ID><value>C0010481</value></FP_Condition_ID><FP_SubChap_LinkTo><value>http://www.fpnotebook.com/Endo/Adrenal/CshngsDs.htm</value></FP_SubChap_LinkTo><FP_Condition_aka><value>Aka: Cushing's Disease, Cushing's Syndrome</value></FP_Condition_aka><FP_SubChap_url>http://www.fpnotebook.com/Endo/Adrenal/index.htm</FP_SubChap_url></item><item><FP_UMLS_Trees><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Pheochromocytoma  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0031511"&gt;&lt;i&gt;C0031511&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CHV)&lt;/td&gt;
                &lt;td&gt;A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CHV)&lt;/td&gt;
                &lt;td&gt;A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CHV)&lt;/td&gt;
                &lt;td&gt;A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CHV)&lt;/td&gt;
                &lt;td&gt;A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CHV)&lt;/td&gt;
                &lt;td&gt;A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MEDLINEPLUS)&lt;/td&gt;
                &lt;td&gt;
                  &lt;span&gt;
                    &lt;p&gt;Pheochromocytoma is a rare tumor that usually starts in the cells of one of your adrenal glands. Although they are usually &lt;a href="http://www.nlm.nih.gov/medlineplus/benigntumors.html"&gt;benign&lt;/a&gt;, pheochromocytomas often cause the adrenal gland to make too many hormones. This can lead to high blood pressure and cause  symptoms such as &lt;/p&gt;
                    &lt;ul&gt;&lt;li&gt;	Headaches&lt;/li&gt;
                      &lt;li&gt;	Sweating&lt;/li&gt;
                      &lt;li&gt;	Pounding of the heart&lt;/li&gt;
                      &lt;li&gt;	Chest pain&lt;/li&gt;
                      &lt;li&gt;	A feeling of anxiety&lt;/li&gt;
                    &lt;/ul&gt;&lt;p&gt;Sometimes pheochromocytoma is part of another condition called multiple endocrine neoplasia syndrome (MEN). People with MEN often have other cancers and other problems involving hormones. &lt;/p&gt;
                    &lt;p&gt;Surgery is the most common treatment.  Other options include radiation therapy and chemotherapy.&lt;/p&gt;
                    &lt;p style="font-weight:bold;font-style:italic;"&gt;NIH: National Cancer Institute&lt;/p&gt;
                  &lt;/span&gt;
                &lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;Tumor that forms in the center of the adrenal gland (gland located above the kidney) that causes it to make too much adrenaline. Pheochromocytomas are usually benign (not cancer) but can cause high blood pressure, pounding headaches, heart palpitations, flushing of the face, nausea, and vomiting.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MSH)&lt;/td&gt;
                &lt;td&gt;A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles &amp;amp; Practice of Oncology, 3d ed, p1298)&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CSP)&lt;/td&gt;
                &lt;td&gt;usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia; the cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (NCI)&lt;/td&gt;
                &lt;td&gt;A benign or malignant neuroendocrine neoplasm of the sympathetic nervous system that secretes catecholamines. It arises from the chromaffin cells of the adrenal medulla. Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor. Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen. Other growth patterns including trabecular pattern may also be present.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Neoplastic Process (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0031511&amp;amp;tui=T191"&gt;&lt;i&gt;T191&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;MSH&lt;/td&gt;
                &lt;td&gt;D010673&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD10&lt;/td&gt;
                &lt;td&gt;M8700/0&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;302835009, 85583005, 399343007, 360335004, 360332001, 154555009, 188337000, 269615000&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;Pheochromocytomas, CHROMAFFINOMA, MEDULLARY, PARAGANGLIOMA, MEDULLARY, PHAEOCHROMOCYTOMA, Pheochromocytoma, NOS, Phaeochromocytoma, NOS, Adrenal Medullary Paraganglioma, Adrenal Medullary Pheochromocytoma, Adrenal Pheochromocytoma, Intraadrenal Paraganglioma, Chromaffin Paraganglioma of the Adrenal Gland, Adrenal Gland Chromaffin Paraganglioma, Adrenal Gland Chromaffinoma, Adrenal Gland Paraganglioma, Adrenal Gland Pheochromocytoma, PHEOCHROMOCYTOMA, Pheochromocytoma, adrenal, Pheochromocytoma syndrome, [M]Pheochromocytoma NOS, Phaeochromocytoma NOS, Pheochromocytoma NOS, chromaffinoma, Pheochromocytoma [Disease/Finding], chromaffin tumor, pheochromocytoma syndrome, pheochromocytomas, phaeochromocytoma, Chromaffin paraganglioma, Chromaffin tumor, Chromaffinoma, Chromaffin tumour, Phaeochromocytoma, [M]Phaeochromocytoma NOS, Chromaffinoma (disorder), Adrenal medullary paraganglioma, Pheochromocytoma (disorder), Pheochromocytoma (morphologic abnormality), pheochromocytoma, Chromaffin paraganglioma (disorder), Phaeochromocytoma (disorder), Phaeochromocytoma [Ambiguous], Pheochromocytoma, PCC&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;PHEOCHROMOCYTOME, Chromaffinome, Phéochromocytome&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;FEOCROMOCITOMA, Feocromocitoma, Feocromocitoma Extra-Adrenal&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;FEOCROMOCITOMA, Pheochromocytoma, Phaeochromocytoma, cromafinoma (trastorno), cromafinoma, feocromocitoma (anomalía morfológica), feocromocitoma (trastorno), feocromocitoma, SAI, feocromocitoma, paraganglioma cromafín, paraganglioma de células argentafines (trastorno), paraganglioma de células argentafines, paraganglioma de células cromafines, tumor cromafín, tumor de células cromafines, Feocromocitoma&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;PHAEOCHROMOZYTOM, Phaeochromozytom, Phäochromozytom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Swedish&lt;/td&gt;
                &lt;td&gt;Feokromocytom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;ｶｯｼｮｸｻｲﾎﾞｳｼｭ, 褐色細胞腫, かっ色細胞腫, クロム親和細胞腫, クロム親和性細胞腫, 髄質細胞腫, 好クロム性細胞腫&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;feochromocytom, Feochromocytom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Finnish&lt;/td&gt;
                &lt;td&gt;Feokromosytooma&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Russian&lt;/td&gt;
                &lt;td&gt;FEOKHROMOBLASTOMA, OPUKHOL' KHROMAFINNAIA, KHROMAFFINOMA, FEOKHROMOTSITOMA, ОПУХОЛЬ ХРОМАФИННАЯ, ФЕОХРОМОБЛАСТОМА, ФЕОХРОМОЦИТОМА, ХРОМАФФИНОМА&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Croatian&lt;/td&gt;
                &lt;td&gt;FEOKROMOCITOM&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Polish&lt;/td&gt;
                &lt;td&gt;Przyzwojak chromochłonny, Guz chromochłonny nadnerczy, Pheochromocytoma, Barwiak&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Phaeochromocytoma, Phaeocromocytoma&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;feochromocytoom, Feochromocytoom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Feocromocitoma&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Paroxysmal hypertension  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0221154"&gt;&lt;i&gt;C0221154&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Sign or Symptom (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0221154&amp;amp;tui=T184"&gt;&lt;i&gt;T184&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;23130000&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;HYPERTENSION, PAROXYSMAL, Hypertension, paroxysmal, paroxysmal hypertension (physical finding), paroxysmal hypertension, paroxysmal hypertension was observed, Hypertension paroxysmal, Paroxysmal hypertension, Paroxysmal hypertension (disorder), Paroxysmal Hypertension&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;paroxysmale hypertensie&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;Hypertension paroxystique&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;Hypertonie, paroxysmal&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Ipertensione parossistica&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;Hipertensão paroxística&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;Hipertensión paroxística, hipertensión arterial paroxística (trastorno), hipertensión arterial paroxística&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;発作性高血圧, ﾎｯｻｾｲｺｳｹﾂｱﾂ&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;Paroxysmální hypertenze&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Paroxysmalis hypertonia&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value></FP_UMLS_Trees><FP_Condition_name_check><value>Pheochromocytoma  (</value><value>)
</value><value>Paroxysmal hypertension  (</value><value>)
</value></FP_Condition_name_check><FP_Condition_name><value>Pheochromocytoma</value></FP_Condition_name><FP_SubChap_name><value>Endocrinology: Adrenal Disease</value></FP_SubChap_name><FP_Condition_Tree><value>&lt;ol&gt;&lt;li&gt;Definition&lt;ol&gt;&lt;li&gt;&lt;a href="../../Neuro/Pharm/AdrnrgcRcptr.htm" class="LinkPage"&gt;Catecholamine&lt;/a&gt; secreting tumor of the &lt;a href="../../Endo/Anatomy/AdrnlAntmy.htm" class="LinkPage"&gt;Adrenal Gland&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Epidemiology&lt;ol&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/DsIncdncRt.htm" class="LinkPage"&gt;Incidence&lt;/a&gt;: Rare&lt;/li&gt;&lt;li&gt;Peak ages: 30-60 years&lt;/li&gt;&lt;li&gt;&lt;a href="../../Pharm/Nutrition/NnNtrtvSwtnr.htm" class="LinkPage"&gt;Equal&lt;/a&gt; male and female predominance&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Presentation: Classic Episodes&lt;ol&gt;&lt;li&gt;Predominant Symptoms&lt;ol&gt;&lt;li&gt;&lt;a href="../../Neuro/Sx/Hdch.htm" class="LinkPage"&gt;Headache&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Diaphoresis or Sweating&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Sx/Plptn.htm" class="LinkPage"&gt;Palpitation&lt;/a&gt;s&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Associated Symptoms&lt;ol&gt;&lt;li&gt;Anxiety&lt;/li&gt;&lt;li&gt;&lt;a href="../../Neuro/Tremor/Trmr.htm" class="LinkPage"&gt;Tremor&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Pallor&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Sx/ChstPn.htm" class="LinkPage"&gt;Chest Pain&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Surgery/GI/EpgstrcPn.htm" class="LinkPage"&gt;Epigastric Pain&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Gyn/Sx/VsmtrSymptmsOfMnps.htm" class="LinkPage"&gt;Flushing&lt;/a&gt; (rare)&lt;/li&gt;&lt;li&gt;Painless &lt;a href="../../Uro/Urine/HmtrInAdlts.htm" class="LinkPage"&gt;Hematuria&lt;/a&gt; (rare)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Timing of episodes&lt;ol&gt;&lt;li&gt;Duration: One hour or less&lt;/li&gt;&lt;li&gt;Frequency: daily to once every few months&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Presentation: Other&lt;ol&gt;&lt;li&gt;Hyperadrenergic spells (see classic episodes above)&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Htn/RstntHyprtnsn.htm" class="LinkPage"&gt;Resistant Hypertension&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Malignant or intra-operative &lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/HME/FmlyHstry.htm" class="LinkPage"&gt;Family History&lt;/a&gt; of Pheochromocytoma or predisposing syndromes (e.g. MEN 2, NF1, VHL. SDH)&lt;/li&gt;&lt;li&gt;Premature &lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt; (age under 20 years)&lt;/li&gt;&lt;li&gt;Idiopathic &lt;a href="../../CV/CHF/SystlcDysfnctn.htm" class="LinkPage"&gt;Dilated Cardiomyopathy&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Diagnostic Clues&lt;ol&gt;&lt;li&gt;Six "H's"&lt;ol&gt;&lt;li&gt;&lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Neuro/Sx/Hdch.htm" class="LinkPage"&gt;Headache&lt;/a&gt; - throbbing (90%)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Derm/Sweat/Hyprhdrs.htm" class="LinkPage"&gt;Hyperhidrosis&lt;/a&gt; or excessive sweating (69%)&lt;/li&gt;&lt;li&gt;Heart consciousness or &lt;a href="../../CV/Sx/Plptn.htm" class="LinkPage"&gt;Palpitation&lt;/a&gt;s (73%)&lt;/li&gt;&lt;li&gt;Hypermetabolism&lt;/li&gt;&lt;li&gt;&lt;a href="../../Endo/Lab/SrmGlcs.htm" class="LinkPage"&gt;Hyperglycemia&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Rule of 10&lt;ol&gt;&lt;li&gt;Familial (10%)&lt;/li&gt;&lt;li&gt;Malignant (10%)&lt;/li&gt;&lt;li&gt;Multiple or Bilateral (10%)&lt;/li&gt;&lt;li&gt;Extra-adrenal (10%)&lt;/li&gt;&lt;li&gt;Childhood onset (10%)&lt;/li&gt;&lt;li&gt;Recurrence after Surgery (10%)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Differential Diagnosis&lt;ol&gt;&lt;li&gt;Primary &lt;a href="../../Endo/Adrenal/Hyprldstrnsm.htm" class="LinkPage"&gt;Aldosteronism&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../GI/HemeOnc/CrcndTmr.htm" class="LinkPage"&gt;Carcinoid&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Accelerated or &lt;a href="../../CV/Htn/HyprtnsnMngmntFrSpcfcEmrgncs.htm" class="LinkPage"&gt;Malignant Hypertension&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Illicit, OTC or prescribed &lt;a href="../../Neuro/Pharm/AdrnrgcRcptr.htm" class="LinkPage"&gt;Sympathomimetic&lt;/a&gt; medications&lt;/li&gt;&lt;li&gt;&lt;a href="../../ENT/HemeOnc/Chmdctm.htm" class="LinkPage"&gt;Chemodectoma&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Neuro/Anatomy/GnglnAntmy.htm" class="LinkPage"&gt;Ganglion&lt;/a&gt;euroma&lt;/li&gt;&lt;li&gt;&lt;a href="../../Endo/Thyroid/Hyprthyrdsm1.htm" class="LinkPage"&gt;Thyrotoxicosis&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Gyn/Endo/Mnps.htm" class="LinkPage"&gt;Menopause&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Psych/Anxiety/PncDsrdr.htm" class="LinkPage"&gt;Panic Disorder&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Antihypertensive withdrawal (e.g. &lt;a href="../../CV/Pharm/AlphAdrnrgcCntrlAgnst.htm" class="LinkPage"&gt;Clonidine&lt;/a&gt; withdrawal)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Labs: Preparation&lt;ol&gt;&lt;li&gt;Stop any interfering medications&lt;ol&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/Lbtl.htm" class="LinkPage"&gt;Labetalol&lt;/a&gt; (stop for 1 week)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Psych/Pharm/TrcyclcAntdprsnt.htm" class="LinkPage"&gt;Tricyclic Antidepressant&lt;/a&gt; (stop for 2 weeks)&lt;/li&gt;&lt;li&gt;Psychoactive medications (stop for weeks)&lt;/li&gt;&lt;li&gt;Levodopa or &lt;a href="../../CV/Pharm/AlphAdrnrgcCntrlAgnst.htm" class="LinkPage"&gt;Methyldopa&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../ENT/Pharm/Dcngstnt.htm" class="LinkPage"&gt;Decongestant&lt;/a&gt;s&lt;/li&gt;&lt;li&gt;&lt;a href="../../Psych/Pharm/Bnzdzpn.htm" class="LinkPage"&gt;Benzodiazepine&lt;/a&gt;s&lt;/li&gt;&lt;li&gt;Muscle relaxants (mephenasin, &lt;a href="../../Rheum/Pharm/SkltlMsclRlxnt.htm" class="LinkPage"&gt;Methocarbamol&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;Avoid &lt;a href="../../Pharm/Analgesic/Actmnphn.htm" class="LinkPage"&gt;Tylenol&lt;/a&gt; for 48 hours&lt;/li&gt;&lt;li&gt;Avoid &lt;a href="../../Pharm/Analgesic/Asprn.htm" class="LinkPage"&gt;Aspirin&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Stop other interfering agents&lt;ol&gt;&lt;li&gt;No &lt;a href="../../Pharm/Nutrition/Cfn.htm" class="LinkPage"&gt;Caffeine&lt;/a&gt;, &lt;a href="../../Psych/Pharm/Alchl.htm" class="LinkPage"&gt;Alcohol&lt;/a&gt; or &lt;a href="../../Psych/CD/Cgrt.htm" class="LinkPage"&gt;Tobacco&lt;/a&gt; for 4 hours&lt;/li&gt;&lt;li&gt;Tomatoes&lt;/li&gt;&lt;li&gt;Walnuts&lt;/li&gt;&lt;li&gt;Pineapple&lt;/li&gt;&lt;li&gt;Banana&lt;/li&gt;&lt;li&gt;Eggplant&lt;/li&gt;&lt;li&gt;Avocado&lt;/li&gt;&lt;li&gt;Plums&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Labs: Available Tests&lt;ol&gt;&lt;li&gt;Best studies&lt;ol&gt;&lt;li&gt;&lt;a href="../../Endo/Lab/UrnMtnphrn.htm" class="LinkPage"&gt;Urine Metanephrine&lt;/a&gt;s (24 hour collections)&lt;ol&gt;&lt;li&gt;Use as first line screening&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSnstvty.htm" class="LinkPage"&gt;Test Sensitivity&lt;/a&gt;: 76%&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSpcfcty.htm" class="LinkPage"&gt;Test Specificity&lt;/a&gt;: 94%&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Plasma Free Metanephrines&lt;ol&gt;&lt;li&gt;Very high false positive rate (Pheochromocytoma is rare)&lt;/li&gt;&lt;li&gt;Use only for confirmation, not for screening&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSnstvty.htm" class="LinkPage"&gt;Test Sensitivity&lt;/a&gt;: 99%&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSpcfcty.htm" class="LinkPage"&gt;Test Specificity&lt;/a&gt;: 89%&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Tests with lower efficacy&lt;ol&gt;&lt;li&gt;Urinary VMA&lt;ol&gt;&lt;li&gt;Normal value under 6.5 mg/day&lt;/li&gt;&lt;li&gt;Imprecise test&lt;/li&gt;&lt;li&gt;Drugs and food interfere with test&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSnstvty.htm" class="LinkPage"&gt;Test Sensitivity&lt;/a&gt;: 63%&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSpcfcty.htm" class="LinkPage"&gt;Test Specificity&lt;/a&gt;: 94%&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Plasma &lt;a href="../../Neuro/Pharm/AdrnrgcRcptr.htm" class="LinkPage"&gt;Catecholamine&lt;/a&gt;s (&lt;a href="../../CV/Pharm/Nrpnphrn.htm" class="LinkPage"&gt;Norepinephrine&lt;/a&gt;, &lt;a href="../../CV/Pharm/Epnphrn.htm" class="LinkPage"&gt;Epinephrine&lt;/a&gt;)&lt;ol&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSnstvty.htm" class="LinkPage"&gt;Test Sensitivity&lt;/a&gt;: 85%&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSpcfcty.htm" class="LinkPage"&gt;Test Specificity&lt;/a&gt;: 80%&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Labs: Protocol&lt;ol&gt;&lt;li&gt;First: &lt;a href="../../Endo/Lab/UrnMtnphrn.htm" class="LinkPage"&gt;24-hour Urine Metanephrine&lt;/a&gt; and &lt;a href="../../Endo/Lab/UrnVnlylmndlcAcd.htm" class="LinkPage"&gt;Urine VMA&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Next: Plasma Free Metanephrines&lt;/li&gt;&lt;li&gt;Next: Plasma &lt;a href="../../Neuro/Pharm/AdrnrgcRcptr.htm" class="LinkPage"&gt;Catecholamine&lt;/a&gt;s (equivocal metanephrines)&lt;/li&gt;&lt;li&gt;Final: &lt;a href="../../Endo/Lab/ClndnSprsnTst.htm" class="LinkPage"&gt;Clonidine Suppression&lt;/a&gt; (positive &lt;a href="../../Neuro/Pharm/AdrnrgcRcptr.htm" class="LinkPage"&gt;Catecholamine&lt;/a&gt;s)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Radiology: Tumor localization&lt;ol&gt;&lt;li&gt;Adrenal CT or Adrenal MRI&lt;ol&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSnstvty.htm" class="LinkPage"&gt;Test Sensitivity&lt;/a&gt;: 93 to 100%&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSpcfcty.htm" class="LinkPage"&gt;Test Specificity&lt;/a&gt;: 70%&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;MIGB Scan (metaiodobenzyl-guanidine)&lt;ol&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSnstvty.htm" class="LinkPage"&gt;Test Sensitivity&lt;/a&gt;: 77 to 90%&lt;/li&gt;&lt;li&gt;&lt;a href="../../Prevent/Epi/TstSpcfcty.htm" class="LinkPage"&gt;Test Specificity&lt;/a&gt;: 95 to 100%&lt;/li&gt;&lt;li&gt;Good for looking for tumors in unusual places&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Management&lt;ol&gt;&lt;li&gt;Preoperative Medical Management&lt;ol&gt;&lt;li&gt;&lt;a href="../../Neuro/Pharm/AlphAdrnrgcRcptr.htm" class="LinkPage"&gt;Alpha Adrenergic Receptor&lt;/a&gt; antagonist (2 weeks pre-op)&lt;ol&gt;&lt;li&gt;Phenoxybenzamine PO bid&lt;/li&gt;&lt;li&gt;Phentolamine IV prn&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/BtBlckr.htm" class="LinkPage"&gt;Beta Blocker&lt;/a&gt; (only start after alpha blockade)&lt;ol&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/Prprnl.htm" class="LinkPage"&gt;Propranolol&lt;/a&gt; PO qid&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Surgical Management&lt;ol&gt;&lt;li&gt;Laparoscopic adrenalectomy Indications&lt;ol&gt;&lt;li&gt;Single, small adrenal tumors&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt; controlled&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Open Adrenalectomy&lt;ol&gt;&lt;li&gt;Adrenal tumor size over 7 cm&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Intra-Operative Management&lt;ol&gt;&lt;li&gt;Continuous Arterial-line &lt;a href="../../CV/Exam/BldPrsr.htm" class="LinkPage"&gt;Blood Pressure&lt;/a&gt; Monitoring&lt;/li&gt;&lt;li&gt;Treat &lt;a href="../../CV/Exam/Hyptnsn.htm" class="LinkPage"&gt;Hypotension&lt;/a&gt;&lt;ol&gt;&lt;li&gt;Fluid management&lt;/li&gt;&lt;li&gt;Consider pressor support&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Treat &lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt;&lt;ol&gt;&lt;li&gt;Phentolamine&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/Ntrprsd.htm" class="LinkPage"&gt;Nitroprusside&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Treat &lt;a href="../../CV/EKG/Tchycrd.htm" class="LinkPage"&gt;Tachycardia&lt;/a&gt; or ectopy&lt;ol&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/BtBlckr.htm" class="LinkPage"&gt;Beta Blocker&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Adjunctive treatment for malignant Pheochromocytoma&lt;ol&gt;&lt;li&gt;&lt;a href="../../HemeOnc/Pharm/Chmthrpy.htm" class="LinkPage"&gt;Chemotherapy&lt;/a&gt;&lt;ol&gt;&lt;li&gt;Cyclophosphamide&lt;/li&gt;&lt;li&gt;Dacarbazine&lt;/li&gt;&lt;li&gt;Vincristine&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;MIGB (metaiodobenzyl-guanidine &lt;a href="../../Endo/Pharm/Rdn.htm" class="LinkPage"&gt;I-131&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;Metyrosine 1 gram every 6 hours&lt;ol&gt;&lt;li&gt;Depletes tumor &lt;a href="../../Neuro/Pharm/AdrnrgcRcptr.htm" class="LinkPage"&gt;Catecholamine&lt;/a&gt; stores&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Course&lt;ol&gt;&lt;li&gt;Persistent &lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt; in 25% of treated patients&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Monitoring&lt;ol&gt;&lt;li&gt;Screen &lt;a href="../../Endo/Lab/UrnMtnphrn.htm" class="LinkPage"&gt;Urine Metanephrine&lt;/a&gt;s annually&lt;/li&gt;&lt;li&gt;Screen Urine &lt;a href="../../Neuro/Pharm/AdrnrgcRcptr.htm" class="LinkPage"&gt;Catecholamine&lt;/a&gt;s annually&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;References&lt;ol&gt;&lt;li&gt;Bailey (2001) CMEA Medicine Lecture, San Diego&lt;/li&gt;&lt;li&gt;(Feb 2001) Ann Intern Med&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
          &lt;/ol&gt;</value></FP_Condition_Tree><FP_Condition_ID><value>C0031511</value><value>C0221154</value></FP_Condition_ID><FP_SubChap_LinkTo><value>http://www.fpnotebook.com/Endo/Adrenal/Phchrmcytm.htm</value></FP_SubChap_LinkTo><FP_Condition_aka><value>Aka: Pheochromocytoma, Paroxysmal Hypertension</value></FP_Condition_aka><FP_SubChap_url>http://www.fpnotebook.com/Endo/Adrenal/index.htm</FP_SubChap_url></item><item><FP_UMLS_Trees><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Hyperaldosteronism  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0020428"&gt;&lt;i&gt;C0020428&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MSH)&lt;/td&gt;
                &lt;td&gt;A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CSP)&lt;/td&gt;
                &lt;td&gt;abnormality of electrolyte function caused by excessive secretion of aldosterone by the adrenal cortex.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Disease or Syndrome (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C0020428&amp;amp;tui=T047"&gt;&lt;i&gt;T047&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;MSH&lt;/td&gt;
                &lt;td&gt;D006929&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD9&lt;/td&gt;
                &lt;td&gt;255.10, 255.1&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD10&lt;/td&gt;
                &lt;td&gt;E26, E26.9&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;190509005, 88213004, 190506003, 154709005, 267484005&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;Aldosteronism, Hyperaldosteronism, ALDOSTERONISM, HYPERALDOSTERONISM, Aldosteronism, NOS, Hyperaldosteronism, NOS, Hyperaldosteronism NOS, Hyperaldosteronism, unspecified, aldosteronism, aldosteronism (diagnosis), hyperaldosteronism, Aldosteronism NOS, Hyperaldosteronism NOS (disorder), Hyperaldosteronism [Disease/Finding], Aldosteronism (disorder)&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;aldosteronisme NAO, aldosteronisme, Hyperaldosteronisme, niet gespecificeerd, hyperaldosteronisme, Aldosteronisme, Aldosteronisme, hyper-, Hyperaldosteronisme&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;Aldostéronisme SAI, Aldostéronisme, Hyperaldostéronisme, Hyperaldostéronisme primitif&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;Aldosteronismus NNB, Hyperaldosteronismus, nicht naeher bezeichnet, Aldosteronismus, Hyperaldosteronismus&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Aldosteronismo NAS, Aldosteronismo, Iperaldosteronismo&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;Aldosteronismo NE, Hiperaldosteronismo, Aldosteronismo&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;Aldosteronismo NEOM, Hyperaldosteronism, Aldosteronism, aldosteronismo con hiperplasia de la corteza suprarrenal, hiperaldosteronismo (trastorno), hiperaldosteronismo, SAI (trastorno), hiperaldosteronismo, SAI, hiperaldosteronismo, Hiperaldosteronismo, Aldosteronismo&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;アルドステロン症ＮＯＳ, ｱﾙﾄﾞｽﾃﾛﾝｼｮｳ, ｱﾙﾄﾞｽﾃﾛﾝｼｮｳNOS, ｺｳｱﾙﾄﾞｽﾃﾛﾝｼｮｳ, コン症候群, アルドステロン過剰症, アルドステロン過剰, アルドステロン症, 高アルドステロン症, Conn症候群&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Swedish&lt;/td&gt;
                &lt;td&gt;Hyperaldosteronism&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;aldosteronismus, hyperaldosteronismus, Aldosteronismus, Aldosteronismus NOS, Hyperaldosteronismus&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Finnish&lt;/td&gt;
                &lt;td&gt;Hyperaldosteronismi&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Russian&lt;/td&gt;
                &lt;td&gt;KONNA SINDROM, GIPERAL'DOSTERONIZM PERVICHNYI, GIPERAL'DOSTERONIZM, AL'DOSTERONIZM, АЛЬДОСТЕРОНИЗМ, ГИПЕРАЛЬДОСТЕРОНИЗМ, ГИПЕРАЛЬДОСТЕРОНИЗМ ПЕРВИЧНЫЙ, КОННА СИНДРОМ&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Korean&lt;/td&gt;
                &lt;td&gt;고알도스테론증, 상세불명의 고알도스테론증&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Croatian&lt;/td&gt;
                &lt;td&gt;HIPERALDOSTERONIZAM&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Polish&lt;/td&gt;
                &lt;td&gt;Aldosteronizm, Zespół Conna, Hiperaldosteronizm pierwotny, Hiperaldosteronizm&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Hyperaldosteronismus k.m.n., Hyperaldosteronismus, Hyperaldosteronizmus&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value><value>&lt;div class="umls"&gt;
            &lt;table&gt;&lt;colgroup&gt;&lt;col class="col1"&gt;&lt;col class="col2"&gt;&lt;/colgroup&gt;&lt;tr&gt;&lt;th colspan="2"&gt;
                  &lt;h3&gt;Conn Syndrome  (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C1384514"&gt;&lt;i&gt;C1384514&lt;/i&gt;&lt;/a&gt;)
&lt;/h3&gt;
                &lt;/th&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (MSH)&lt;/td&gt;
                &lt;td&gt;Primary hyperaldosteronism caused by the excess production of ALDOSTERONE by an ADENOMA of the ZONA GLOMERULOSA or CONN ADENOMA.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Definition (CSP)&lt;/td&gt;
                &lt;td&gt;overproduction of aldosterone by an adrenal cortical adenoma, characterized typically by low potassium levels, underacidity of the body, muscular weakness, excess urination, excess thirst, and high blood pressure.&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Concepts&lt;/td&gt;
                &lt;td&gt;Disease or Syndrome (&lt;a href="http://www.fpnotebook.com/asp3/myaccount/cui.aspx?q=C1384514&amp;amp;tui=T047"&gt;&lt;i&gt;T047&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;MSH&lt;/td&gt;
                &lt;td&gt;D006929&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD9&lt;/td&gt;
                &lt;td&gt;255.12&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ICD10&lt;/td&gt;
                &lt;td&gt;E26.0, E26.01&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;SnomedCT&lt;/td&gt;
                &lt;td&gt;13536004, 258117004, 190507007, 154709005, 190506003, 267484005&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;English&lt;/td&gt;
                &lt;td&gt;ALDOSTERONISM, PRIMARY, CONN SYNDROME, HYPERALDOSTERONISM, PRIMARY, Hyperaldosteronism, primary, PRIMARY HYPERALDOSTERONISM, Aldosteronism Primary, Conn Syndrome, primary hyperaldosteronism, primary aldosteronism (diagnosis), primary aldosteronism, Primary aldosteronism (disorder), Conn's syndrome (diagnosis), Idiopathic aldosteronism, Idiopathic hyperaldosteronism, Conns Syndrome, Conn's Syndrome, Syndrome, Conn's, conn syndrome, conn's syndrome, conns syndrome, Conn's syndrome, Conn syndrome, Primary aldosteronism, Primary hyperaldosteronism, Idiopathic aldosteronism (disorder), Primary hyperaldosteronism (disorder), hyperaldosteronism; primary, primary; hyperaldosteronism, Conn, Primary aldosteronism (disorder) [Ambiguous], Syndrome, Conn, Primary Hyperaldosteronism, Hyperaldosteronism, Primary&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Italian&lt;/td&gt;
                &lt;td&gt;Iperaldosteronismo primitivo, Sindrome di Conn&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Dutch&lt;/td&gt;
                &lt;td&gt;Conn-syndroom, hyperaldosteronisme; primair, primair; hyperaldosteronisme, Primair hyperaldosteronisme, primair hyperaldosteronisme&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;French&lt;/td&gt;
                &lt;td&gt;Syndrome de conn, Syndrome de Conn, Hyperaldostéronisme primaire, Hyperaldostéronisme primaire à rénine basse&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;German&lt;/td&gt;
                &lt;td&gt;Conn-Syndrom, Primaerer Hyperaldosteronismus, primaerer Hyperaldosteronismus&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Portuguese&lt;/td&gt;
                &lt;td&gt;Síndrome de Conn, Hiperaldesteronismo primário&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Spanish&lt;/td&gt;
                &lt;td&gt;Síndrome de Conn, Conn's syndrome, aldosteronismo idiopático, aldosteronismo primario, hiperaldosteronismo idiopático (trastorno), hiperaldosteronismo idiopático, hiperaldosteronismo primario (concepto no activo), hiperaldosteronismo primario (trastorno), hiperaldosteronismo primario, síndrome de Conn, Hiperaldosteronismo primario&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Japanese&lt;/td&gt;
                &lt;td&gt;原発性アルドステロン症, コーン症候群, ｺｰﾝｼｮｳｺｳｸﾞﾝ, ｹﾞﾝﾊﾟﾂｾｲｱﾙﾄﾞｽﾃﾛﾝｼｮｳ&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Czech&lt;/td&gt;
                &lt;td&gt;Primární hyperaldosteronismus, Connův syndrom&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Korean&lt;/td&gt;
                &lt;td&gt;원발성 고알도스테론증&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Croatian&lt;/td&gt;
                &lt;td&gt;CONNOV SINDROM, PRIMARNI HIPERALDOSTERONIZAM&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Hungarian&lt;/td&gt;
                &lt;td&gt;Conn-syndroma, Primaer hyperaldosteronismus&lt;/td&gt;
              &lt;/tr&gt;&lt;tr&gt;&lt;td&gt;
                  &lt;i&gt;Sources&lt;/i&gt;
                &lt;/td&gt;
                &lt;td align="center"&gt;
                  &lt;br&gt;&lt;i&gt;
                    &lt;small&gt;Derived from the NIH UMLS &lt;/small&gt;
                  &lt;/i&gt; (&lt;a href="http://www.nlm.nih.gov/research/umls/"&gt;&lt;i&gt;&lt;small&gt;Unified Medical Language System&lt;/small&gt;&lt;/i&gt;&lt;/a&gt;)
&lt;/td&gt;
              &lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</value></FP_UMLS_Trees><FP_Condition_name_check><value>Hyperaldosteronism  (</value><value>)
</value><value>Conn Syndrome  (</value><value>)
</value></FP_Condition_name_check><FP_Condition_name><value>Hyperaldosteronism</value></FP_Condition_name><FP_SubChap_name><value>Endocrinology: Adrenal Disease</value></FP_SubChap_name><FP_Condition_Tree><value>&lt;ol&gt;&lt;li&gt;Epidemiology&lt;ol&gt;&lt;li&gt;Represents under 1% of &lt;a href="../../CV/Htn/HyprtnsnCs.htm" class="LinkPage"&gt;Hypertension Causes&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Peak age 30-50 years&lt;/li&gt;&lt;li&gt;Most patients are women&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Pathophysiology&lt;ol&gt;&lt;li&gt;Inappropriate Aldosterone Hypersecretion&lt;ol&gt;&lt;li&gt;Primary Hyperaldosteronism (See Causes below)&lt;ol&gt;&lt;li&gt;Increased aldosterone is initiating event&lt;/li&gt;&lt;li&gt;Results in sodium retention and volume increase&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Exam/RnAngtnsnSystm.htm" class="LinkPage"&gt;Renin&lt;/a&gt; decreases&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Secondary Hyperaldosteronism (See Causes below)&lt;ol&gt;&lt;li&gt;Decreased circulating volume is initiating event&lt;/li&gt;&lt;li&gt;Results in increased renin and aldosterone&lt;/li&gt;&lt;li&gt;Results in sodium retention&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Physiologic response to Aldosterone Excess&lt;ol&gt;&lt;li&gt;Increased renal distal tubular sodium reabsorption&lt;ol&gt;&lt;li&gt;Increased total body sodium content&lt;/li&gt;&lt;li&gt;Increased water retention&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Escape phenomenon&lt;ol&gt;&lt;li&gt;Compensatory increased ANF secretion&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt; may not be solely volume expansion&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Increased peripheral vascular resistance&lt;ol&gt;&lt;li&gt;&lt;a href="../../Renal/Potassium/Hypklm.htm" class="LinkPage"&gt;Hypokalemia&lt;/a&gt;: Potassium lost in distal renal tubule&lt;/li&gt;&lt;li&gt;Alkalosis: Ammoniagenesis&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Hydrogen ion loss (avid sodium retention)&lt;/li&gt;&lt;li&gt;Polyuria: Decreased renal concentrating ability&lt;/li&gt;&lt;li&gt;Plasma renin suppressed&lt;ol&gt;&lt;li&gt;Unresponsive to intravascular volume depletion&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Causes&lt;ol&gt;&lt;li&gt;Primary Hyperaldosteronism (Conn's Disease)&lt;ol&gt;&lt;li&gt;Solitary adrenal adenomas (80-90%)&lt;/li&gt;&lt;li&gt;Bilateral adrenal hyperplasia (10-20%)&lt;ol&gt;&lt;li&gt;Idiopathic Hyperaldosteronism&lt;/li&gt;&lt;li&gt;Accounts for 50% of cases at some referral centers&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Adrenal Carcinoma (rare)&lt;/li&gt;&lt;li&gt;Unilateral Adrenal Hyperplasia (very rare)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Secondary Hyperaldosteronism&lt;ol&gt;&lt;li&gt;Hypertensive States&lt;ol&gt;&lt;li&gt;Primary &lt;a href="../../CV/Exam/RnAngtnsnSystm.htm" class="LinkPage"&gt;Renin&lt;/a&gt;ism (rare renin producing tumor)&lt;/li&gt;&lt;li&gt;Secondary reninism due to decreased renal perfusion&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Renal/Edema/Edm.htm" class="LinkPage"&gt;Edema&lt;/a&gt;tous States&lt;ol&gt;&lt;li&gt;&lt;a href="../../GI/Lvr/Crhs.htm" class="LinkPage"&gt;Cirrhosis&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Renal/Glomerulus/NphrtcSyndrm.htm" class="LinkPage"&gt;Nephrotic Syndrome&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Symptoms&lt;ol&gt;&lt;li&gt;Often Asymptomatic&lt;/li&gt;&lt;li&gt;Frontal &lt;a href="../../Neuro/Sx/Hdch.htm" class="LinkPage"&gt;Headache&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Rheum/Sx/MsclWkns.htm" class="LinkPage"&gt;Muscle Weakness&lt;/a&gt; to flaccid paralysis (&lt;a href="../../Renal/Potassium/Hypklm.htm" class="LinkPage"&gt;Hypokalemia&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;Polyuria and Polydipsia (carbohydrate intolerance)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Signs&lt;ol&gt;&lt;li&gt;&lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt;&lt;ol&gt;&lt;li&gt;May be severe&lt;/li&gt;&lt;li&gt;Rarely malignant&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Neuro/Exam/MtrExm.htm" class="LinkPage"&gt;Motor Exam&lt;/a&gt; with decreased &lt;a href="../../Neuro/Exam/MtrExm.htm" class="LinkPage"&gt;Muscle Strength&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Labs&lt;ol&gt;&lt;li&gt;Serum Electrolytes&lt;ol&gt;&lt;li&gt;&lt;a href="../../Renal/Lab/SrmPtsm.htm" class="LinkPage"&gt;Serum Potassium&lt;/a&gt; decreased (&lt;a href="../../Renal/Potassium/Hypklm.htm" class="LinkPage"&gt;Hypokalemia&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Renal/Lab/SrmSdm.htm" class="LinkPage"&gt;Serum Sodium&lt;/a&gt; increased (Mild)&lt;/li&gt;&lt;li&gt;&lt;a href="../../Renal/AcidBase/MtblcAlkls.htm" class="LinkPage"&gt;Metabolic Alkalosis&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Morning Aldosterone to PRA ratio&lt;ol&gt;&lt;li&gt;Ratio over 20-25 (esp if &amp;gt;100) suggests Hyperaldosteronism&lt;/li&gt;&lt;li&gt;Aldosterone &amp;gt;15 ng/dl and plasma renin low&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Saline suppression&lt;ol&gt;&lt;li&gt;IVF: 300-500 cc/hour for 4 hours&lt;/li&gt;&lt;li&gt;Normal response&lt;ol&gt;&lt;li&gt;Aldosterone usually under 0.28&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Exam/RnAngtnsnSystm.htm" class="LinkPage"&gt;Renin&lt;/a&gt; usually suppressed&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Differential Diagnosis: &lt;a href="../../CV/Htn/Hyprtnsn.htm" class="LinkPage"&gt;Hypertension&lt;/a&gt; with &lt;a href="../../Renal/Potassium/Hypklm.htm" class="LinkPage"&gt;Hypokalemia&lt;/a&gt;&lt;ol&gt;&lt;li&gt;&lt;a href="../../Endo/Adrenal/CshngsDs.htm" class="LinkPage"&gt;Cushing's Disease&lt;/a&gt;&lt;ol&gt;&lt;li&gt;Low Aldosterone and Low Plasma &lt;a href="../../CV/Exam/RnAngtnsnSystm.htm" class="LinkPage"&gt;Renin&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="../../Renal/CV/RnlArtryStns.htm" class="LinkPage"&gt;Renal Artery Stenosis&lt;/a&gt; or other renal cause&lt;ol&gt;&lt;li&gt;High Aldosterone and High Plasma &lt;a href="../../CV/Exam/RnAngtnsnSystm.htm" class="LinkPage"&gt;Renin&lt;/a&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
            &lt;li&gt;Management&lt;ol&gt;&lt;li&gt;Adrenal Adenoma&lt;ol&gt;&lt;li&gt;Surgical excision&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Adrenal Hyperplasia&lt;ol&gt;&lt;li&gt;First-Line Agents&lt;ol&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/Sprnlctn.htm" class="LinkPage"&gt;Spironolactone&lt;/a&gt; (&lt;a href="../../CV/Pharm/Sprnlctn.htm" class="LinkPage"&gt;Aldactone&lt;/a&gt;)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Alternative agents if &lt;a href="../../Endo/Sx/Gyncmst.htm" class="LinkPage"&gt;Gynecomastia&lt;/a&gt; develops on &lt;a href="../../CV/Pharm/Sprnlctn.htm" class="LinkPage"&gt;Spironolactone&lt;/a&gt;&lt;ol&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/SlctvAldstrnRcptrAntgnst.htm" class="LinkPage"&gt;Eplerenone&lt;/a&gt; (&lt;a href="../../CV/Pharm/SlctvAldstrnRcptrAntgnst.htm" class="LinkPage"&gt;Inspra&lt;/a&gt;)&lt;/li&gt;&lt;li&gt;&lt;a href="../../CV/Pharm/PtsmSprngDrtc.htm" class="LinkPage"&gt;Amiloride&lt;/a&gt; (&lt;a href="../../CV/Pharm/PtsmSprngDrtc.htm" class="LinkPage"&gt;Midamor&lt;/a&gt;)&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;li&gt;Precautions&lt;ol&gt;&lt;li&gt;Follow &lt;a href="../../Renal/Lab/SrmPtsm.htm" class="LinkPage"&gt;Serum Potassium&lt;/a&gt; and &lt;a href="../../Renal/Lab/SrmCrtn.htm" class="LinkPage"&gt;Serum Creatinine&lt;/a&gt; every 6 months with these agents&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/li&gt;
          &lt;/ol&gt;</value></FP_Condition_Tree><FP_Condition_ID><value>C0020428</value><value>C1384514</value></FP_Condition_ID><FP_SubChap_LinkTo><value>http://www.fpnotebook.com/Endo/Adrenal/Hyprldstrnsm.htm</value></FP_SubChap_LinkTo><FP_Condition_aka><value>Aka: Hyperaldosteronism, Aldosteronism, Conn's Disease, Conn's Syndrome</value></FP_Condition_aka><FP_SubChap_url>http://www.fpnotebook.com/Endo/Adrenal/index.htm</FP_SubChap_url></item></items>